Research shows why cancer stops responding to kinase-blocking drugs and comes back stronger

Research shows why cancer stops responding to kinase-blocking drugs and comes back stronger
More than 70 FDA-approved cancer drugs are kinase inhibitors, which work by blocking kinases — enzymes that add phosphate groups to molecules in the cell — and preventing the chemical activity necessary for signaling and growth in cancer cells…

Published March 13, 2023 at 06:45AM
Read more at nsf.gov

Comments

Post a Comment

Popular posts from this blog

Statement on NSF Fiscal Year 2022 appropriations

Statement on NSF Fiscal Year 2022 appropriations U.S. National Science Foundation Director Sethuraman Panchanathan issued the following statement on the passage of Fiscal Year 2022 appropriations for the agency: The U.S. National Science Foundation has a long history of advancing the frontiers of research through exploration and innovation, making the U.S. a world leader in science and engineering. NSF has produced numerous breakthroughs that have had incredible benefits for the American people. We are grateful for the ... More at https://www.nsf.gov/news/news_summ.jsp?cntn_id=304628&WT.mc_id=USNSF_51&WT.mc_ev=click This is an NSF News item. Published March 14, 2022 at 06:00AM Read more at nsf.gov
Read more

Brought to you by NSF

Image
Brought to you by NSF Every day you encounter something made possible by the National Science Foundation. More at https://www.nsf.gov/news/special_reports/btyb/index.jsp?WT.mc_id=USNSF_51 This is an NSF News item. Published November 04, 2019 at 09:45AM Read more at nsf.gov
Read more